Cite
HARVARD Citation
Tang, H. et al. (2022). Are novel glucose‐lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta‐trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes, obesity & metabolism. 24 (1), pp. 154-159. [Online].